New Study Shows Biden Poised to Break Key Campaign Tax Promise
MaY 9, 2022 Over the past year, President Biden and Senate Democrats have endorsed a proposal that would radically...
In The House of Representatives – Few Cures, Many Ills on Drug Pricing
Yesterday, the House Energy and Commerce Committee debated the merits of H.R.3, a proposal released by Speaker of the House...
Inflationary Price Caps are a Tax on Medicare Part D and Won’t Help Seniors with Drug Costs
July 19, 2019 We recently learned that the White House is asking Senate Democrats to include two proposals in...
CASE Op-Ed – IJR: The US Economy Is Booming. Now the Government Just Needs to Stay Out of Its Way.
Gerard Scimeca – Chairman, CASE August 31, 2018 – https://bit.ly/2xYsfXy Seinfeld’s George Costanza never studied to be an architect, but that didn’t stop...
CASE Denounces BAT as Massive Tax Increase on America’s Working Families
CASE Denounces BAT as Massive Tax Increase on America’s Working Families Today CASE, Consumer Action for a Strong Economy, issued...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/